Financial Results
The material used in the financial results and financial results briefing, which describes qualitative information such as business results,management policies, and financial statements. are posted.
Annual Securities Report
This document discloses company details prepared for each fiscal year in accordance with the Financial Instruments and Exchange Act.
Integrated Report
The Company annually provides its management strategy and ESG information along with a corporate message from its executives.
Shareholder Newsletters
(Japanese version only) We will send our shareholders a biannual shareholders' newsletter containing the latest information on our business, financial results, topics, etc.
Shareholders' Meeting
The date, time, and the venue of the general meeting of shareholders, and the materials available to them are posted.
Fact Sheet
12-Year Summary of Consolidated Financial Results of ASKA Pharmaceutical Holdings are posted.
Top Message
Message to our shareholders and investors from President and Representative Director, Takashi Yamaguchi
Medium-Term Management Plan
The Company's medium- to long-term management strategies
Business Risks
Matters related to business conditions and accounting conditions that may have a significant impact on investors' decisions.
Disclosure policy
Our Disclosure policy to provide timely and appropriate information
Basic Principles/Corporate Governance Structure
Corporate Governance Basic Policy
Corporate Governance Report
(Japanese version only)
Board Members
Compliance / Risk Management
Internal Control System
Dialogue with Shareholders
Roundtable Discussion with Outside Directors
Material Issues: G
ESG Chart and ESG Data Book
Performance Review
Reviews of recent business performance and future outlook of the Company are available here.
Performance Highlights
Graphs and numerical data on Sales, Operating profit, and other key financial figures are available here.
Financial Conditions
Graphs and numerical data on total assets, net assets, and other major financial figures are available here.
Financial Statements
Balance sheets, income statements, and cash flow statements are available here.
Earnings Forecast
Information on our business forecasts is available here.
Non-Financial Highlights
(ESG Chart and ESG Data Book) This page contains non-financial data related to our sustainability.
Point1 About ASKA -Understanding & History–
The history of ASKA Pharmaceutical, from its founding in 1893 to the present, is introduced here with photos.
Point2 About ASKA -Strengths-
ASKA Pharmaceutical's strength comes from its high level of specialization in the three therapeutic areas of internal medicine, obstetrics and gynecology, and urology.
Point3 Highly specialized product lineup
Major products in internal medicine, obstetrics & gynecology, and urology are introduced here.
Point4 Continuously evolving R&D
Aiming to continuously create innovative new drugs with high value, we are working to strengthen our R&D capabilities.
Point5 Stable Shareholder Returns
We regard the return of profits to shareholders as an important management issue and pay stable dividends.
Frequently Asked Questions
Frequently asked questions from shareholders and investors are summarized here.
Stock summary information
Stock information such as fiscal year and shareholder composition are posted.
Shareholder Information
Top 10 Shareholders and Distribution of Shares.
Stock Price Information
Stock price and stock chart.
Dividends and Dividend Payout Ratio
Dividend policy and dividends are available here.
Articles of Incorporation and Stock Handling Regulations
(Japanese version only) Articles of Incorporation and Stock Handling Regulations.
Analyst Coverage
List of analysts covering the Company.